A LinkedIn post from Nabla highlights the company’s planned presence at HIMSS2026, where it will host a Physicians Community Roundtable on “Agentic AI in 2026: How Much Autonomy is Healthcare Ready to Give?”. The session is positioned around real-world integration of agentic AI into healthcare workflows, including EHR connectivity, governance, reliability, and the role of human-in-the-loop oversight.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Nabla’s Chief Medical Officer will moderate a panel of clinical leaders from multiple health systems, suggesting the company is targeting deeper engagement with decision-makers responsible for digital and AI strategy. For investors, this focus may indicate efforts to strengthen thought leadership, validate use cases with frontline clinicians, and potentially accelerate enterprise adoption of its AI solutions in the competitive healthcare technology market.